Caladan Bio specializes in next-generation bioreactors, offering modular, affordable, and cutting-edge solutions.
Caladan Bio has raised $5.1M in total funding. The most recent round was Seed. The last funding was announced in February 2024.
Caladan Bio's investors include Twelve Below, Lerer Hippeau, Collaborative Fund, Wireframe Ventures, Factorial Capital.
Caladan Bio is headquartered in Brooklyn, United States.
Caladan Bio specializes in next-generation bioreactors, offering modular, affordable, and cutting-edge solutions.
Caladan Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Caladan Bio — Funding & Investors." VCBacked, February 13, 2024, https://www.vcbacked.co/company/caladan-bio. Accessed September 4, 2026.
VCBacked. (2024). Caladan Bio — Funding & Investors. Retrieved September 4, 2026, from https://www.vcbacked.co/company/caladan-bio
{{cite web |title=Caladan Bio — Funding & Investors |url=https://www.vcbacked.co/company/caladan-bio |website=VCBacked |access-date=September 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated